Prostate Cancer Clinical Trial
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.
Patient is at least 18 years of age
Diagnosis of metastatic prostate cancer
Ability to understand and the willingness to sign a written informed consent document
Enrolled in another research study
Patients with psychiatric illness/social situations that would limit compliance with study requirements
Inability to provide written informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.